Skip to content
10-Q

Quarterly Report

CME GROUP INC. CME

0001156375-26-000020

← back to feed
Filed
Apr 24, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q1 2026 · Mar 31, 2026 363.21M sh
Shares Diluted Q1 2026 · Mar 31, 2025 360.23M sh
Dividends Paid Q1 2026 · Mar 31, 2026 $2.7B
Dividends Paid Q1 2026 · Mar 31, 2025 $2.57B
Capex Q1 2026 · Mar 31, 2026 $21.8M
Capex Q1 2026 · Mar 31, 2025 $14.2M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $1.26B
Operating Cash Flow Q1 2026 · Mar 31, 2025 $1.12B
Cash And Equivalents Q1 2026 · Mar 31, 2026 $2.39B
Cash And Equivalents Q1 2026 · Dec 31, 2025 $4.42B
Cash And Equivalents Q1 2026 · Mar 31, 2025 $1.41B
Stockholders Equity Q1 2026 · Mar 31, 2026 $26.62B
Stockholders Equity Q1 2026 · Dec 31, 2025 $28.73B
Current Liabilities Q1 2026 · Mar 31, 2026 $166B
Current Liabilities Q1 2026 · Dec 31, 2025 $160.3B
Total Liabilities Q1 2026 · Mar 31, 2026 $175.38B
Total Liabilities Q1 2026 · Dec 31, 2025 $169.7B
Current Assets Q1 2026 · Mar 31, 2026 $169B
Current Assets Q1 2026 · Dec 31, 2025 $165.36B
Total Assets Q1 2026 · Mar 31, 2026 $201.99B
Total Assets Q1 2026 · Dec 31, 2025 $198.42B
Eps Diluted Q1 2026 · Mar 31, 2026 $3.18
Eps Diluted Q1 2026 · Mar 31, 2025 $2.62
Eps Basic Q1 2026 · Mar 31, 2026 $3.25
Eps Basic Q1 2026 · Mar 31, 2025 $2.63
Operating Income Q1 2026 · Mar 31, 2026 $1.31B
Operating Income Q1 2026 · Mar 31, 2025 $1.11B
Revenue Q1 2026 · Mar 31, 2026 $1.88B
Revenue Q1 2026 · Mar 31, 2025 $1.64B